Why UnitedHealth Group Stock Lost 17% in December
Shares of UnitedHealth Group (NYSE: UNH) were pulling back in December due to a backlash against the company following the murder of one of its executives and reports of a potential crackdown on pharmacy benefit managers (PBMs), including UnitedHealth's OptumRx.
Other media reports also shone a harsh light on the business and could lead to more regulation or an overhaul of some healthcare industry practices.
According to data from S&P Global Market Intelligence, the stock lost 17% last month. As you can see from the chart, the stock fell in three stages over the first half of December, and then traded sideways for the rest of the month.
Source Fool.com
UnitedHealth Group Inc. Aktie
346,40 €
-1,31 %
Klarer Community-Favorit: UnitedHealth Group Inc. mit vielen Buy- und wenigen Sell-Einschätzungen.
Das Kursziel von 366 € für UnitedHealth Group Inc. weist auf eine leichte Verbesserung gegenüber dem aktuellen Kurs von 346.4 € hin.
